GLUCOR Side Effects

7009989-8 | Diarrhoea, Dysarthria, Facial Asymmetry, Hypoglycaemia, Metabolic Acidosis, Syncope, Vision Blurred
on Sep 09, 2010 Male patient from FRANCE , 67 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, cardiac failure and was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dysarthria, facial asymmetry, hypoglycaemia, metabolic acidosis, syncope, vision blurred. Glucor dosage: As Used: 3 X 1 Df. During the same period patient was treated with GLUCOPHAGE (As Used: 3 X 1 Df) (View Glucophage Review and Glucophage Label ), DIAMICRON (As Used: 3 X 1 Df) (View Diamicron Review and Diamicron Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMERIT (View Temerit Review and Temerit Label ). Patient was hospitalized.

7005192-6 | Diarrhoea, Dysarthria, Facial Asymmetry, Hypoglycaemia, Metabolic Acidosis, Syncope, Vision Blurred
Patient was taking Glucor (View Usage). Patient had the following side effects: diarrhoea, dysarthria, facial asymmetry, hypoglycaemia, metabolic acidosis, syncope, vision blurred on Sep 09, 2010 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with type 2 diabetes mellitus, hypertension, cardiac failure and. Glucor dosage: As Used: 3 X 1 Df. During the same period patient was treated with GLUCOPHAGE (As Used: 3 X 1 Df) (View Glucophage Review and Glucophage Label ), DIAMICRON (As Used: 3 X 1 Df) (View Diamicron Review and Diamicron Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMERIT (View Temerit Review and Temerit Label ). Patient was hospitalized.

6967806-6 | Purpura
Adverse event was reported on Aug 27, 2010 by a Female patient taking Glucor (View Usage) (Dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg) was diagnosed with type 2 diabetes mellitus, dyslipidaemia and. Location: FRANCE , 71 years of age, After Glucor was administered, patient had the following side effects: purpura. During the same period patient was treated with VASTEN (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Vasten Review and Vasten Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MICARDIS HCT (80 Mg/12.5 Mg (hydrochlorothiazide, Telmisartan )) (View Micardis Hct Review and Micardis Hct Label ), INIPOMP (View Inipomp Review and Inipomp Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

6967787-5 | Pancreatitis
on Aug 27, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Glucor dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with XELEVIA (Total Daily Dose: 100 Mg) (View Xelevia Review and Xelevia Label ), TAHOR (Total Daily Dose: 20 Mg) (View Tahor Review and Tahor Label ), LOXEN LP (Since 15 Years) (View Loxen Lp Review and Loxen Lp Label ), FORTZAAR (100/25 (hydrochlorothiazide, Losartan Potassium) Since One Year) (View Fortzaar Review and Fortzaar Label ), DIAMICRON LP (Following Glycosylated Hemoglobin Of 7,8 % And Withdrawn For 15 Days) (View Diamicron Lp Review and Diamicron Lp Label ). Patient was hospitalized.


6781644-9 | Rash Maculo-papular, Rash Papular
on May 28, 2010 Female patient from FRANCE , 91 years of age, was diagnosed with erysipelas and was treated with Glucor (View Usage). Patient had the following side effects: rash maculo-papular, rash papular. Glucor dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), PLAVIX (View Plavix Review and Plavix Label ), ROVAMYCIN (View Rovamycin Review and Rovamycin Label ), CLAMOXYL (Taken Twice) (View Clamoxyl Review and Clamoxyl Label ), LOVENOX (View Lovenox Review and Lovenox Label ), CELECTOL (View Celectol Review and Celectol Label ), HYZAAR (As Used: 50/12.5 Mg) (View Hyzaar Review and Hyzaar Label ), LASIX (As Used: 20/2 Mg/ml) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6781639-5 | Stevens-johnson Syndrome
Patient was taking Glucor (View Usage). After Glucor was administered, patient had the following side effects: stevens-johnson syndrome on Jun 10, 2010 from FRANCE Additional patient health information: Female patient , 85 years of age, was diagnosed with diabetes mellitus, gout (What is gout?), hypertension, glaucoma (What is glaucoma?) and. Glucor dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CELIPROLOL (View Celiprolol Review and Celiprolol Label ), XALATAN (View Xalatan Review and Xalatan Label ), LIPOSIC (View Liposic Review and Liposic Label ). Patient was hospitalized.

6781627-9 | Decreased Appetite, Dermatitis Exfoliative, Insomnia, Lichenoid Keratosis, Pruritus
Adverse event was reported on Jun 08, 2010 by a Male patient taking Glucor (View Usage) (Dosage: Unit Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, transient ischaemic attack, hypertension, bladder cancer (What is bladder cancer?) and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: decreased appetite, dermatitis exfoliative, insomnia, lichenoid keratosis, pruritus. During the same period patient was treated with METFORMIN HCL (Unit Dose: 1 G) (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), OMEXEL (Total Daily Dose: 0.4 Mg Unit Dose: 0.4 Mg) (View Omexel Review and Omexel Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ATARAX (View Atarax Review and Atarax Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6770533-1 | Altered State Of Consciousness, Hypoglycaemia
on Apr 26, 2010 Female patient from FRANCE , 94 years of age, was diagnosed with diabetes mellitus and was treated with Glucor (View Usage). Patient had the following side effects: altered state of consciousness, hypoglycaemia. Glucor dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with GLIBENESE (Total Daily Dose: 15 Mg Unit Dose: 5 Mg) (View Glibenese Review and Glibenese Label ), MEDIATOR (Total Daily Dose: 150 Mg Unit Dose: 150 Mg) (View Mediator Review and Mediator Label ). Patient was hospitalized.

6762976-7 | Rash Maculo-papular, Rash Papular
on May 28, 2010 Female patient from FRANCE , 91 years of age, was diagnosed with erysipelas and was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: rash maculo-papular, rash papular. Glucor dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), PLAVIX (View Plavix Review and Plavix Label ), ROVAMYCIN (View Rovamycin Review and Rovamycin Label ), CLAMOXYL (Taken Twice) (View Clamoxyl Review and Clamoxyl Label ), LOVENOX (View Lovenox Review and Lovenox Label ), CELECTOL (View Celectol Review and Celectol Label ), HYZAAR (As Used: 50/12.5 Mg) (View Hyzaar Review and Hyzaar Label ), LASIX (As Used: 20/2 Mg/ml) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6749089-5 | Agranulocytosis
Patient was taking Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis on Apr 06, 2010 from FRANCE Additional patient health information: Female patient , 94 years of age, . Glucor dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), SMECTA (DIOSMECTITE) (View Smecta (diosmectite) Review and Smecta (diosmectite) Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6749085-8 | Convulsion, Hypocalcaemia, Hypoglycaemia, Hypomagnesaemia
Adverse event was reported on Mar 26, 2010 by a Female patient taking Glucor (View Usage) (Dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg) was diagnosed with diabetes mellitus, device related infection and. Location: FRANCE , 72 years of age, Patient had the following side effects: convulsion, hypocalcaemia, hypoglycaemia, hypomagnesaemia. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), MERONEM (View Meronem Review and Meronem Label ), SULFAMIDE (View Sulfamide Review and Sulfamide Label ). Patient was hospitalized.

6715315-1 | Altered State Of Consciousness, Hypoglycaemia
on Apr 26, 2010 Female patient from FRANCE , 94 years of age, was diagnosed with diabetes mellitus and was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: altered state of consciousness, hypoglycaemia. Glucor dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with GLIBENESE (Total Daily Dose: 15 Mg Unit Dose: 5 Mg) (View Glibenese Review and Glibenese Label ), MEDIATOR (Total Daily Dose: 150 Mg Unit Dose: 150 Mg) (View Mediator Review and Mediator Label ). Patient was hospitalized.

6684216-X | Agranulocytosis
on Apr 06, 2010 Female patient from FRANCE , 94 years of age, was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis. Glucor dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), DAONIL (View Daonil Review and Daonil Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), SMECTA (DIOSMECTITE) (View Smecta (diosmectite) Review and Smecta (diosmectite) Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6670834-1 | Convulsion, Hypocalcaemia, Hypoglycaemia, Hypomagnesaemia
Patient was taking Glucor (View Usage). Patient had the following side effects: convulsion, hypocalcaemia, hypoglycaemia, hypomagnesaemia on Mar 26, 2010 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with diabetes mellitus, device related infection and. Glucor dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), MERONEM (View Meronem Review and Meronem Label ), SULFAMIDE (View Sulfamide Review and Sulfamide Label ). Patient was hospitalized.

6621116-5 | Decreased Appetite, Dermatitis Exfoliative, Insomnia, Lichenoid Keratosis, Pruritus
Adverse event was reported on Feb 05, 2010 by a Male patient taking Glucor (View Usage) (Dosage: Unit Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, transient ischaemic attack, hypertension, bladder cancer (What is bladder cancer?) and. Location: FRANCE , 78 years of age, After Glucor was administered, patient had the following side effects: decreased appetite, dermatitis exfoliative, insomnia, lichenoid keratosis, pruritus. During the same period patient was treated with METFORMIN HCL (Unit Dose: 1 G) (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), OMEXEL (Total Daily Dose: 0.4 Mg Unit Dose: 0.4 Mg) (View Omexel Review and Omexel Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6585626-1 | Decreased Appetite, Dermatitis Exfoliative, Insomnia, Lichenoid Keratosis, Pruritus
on Feb 05, 2010 Male patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus, transient ischaemic attack, hypertension, bladder cancer (What is bladder cancer?) and was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dermatitis exfoliative, insomnia, lichenoid keratosis, pruritus. Glucor dosage: Unit Dose: 100 Mg. During the same period patient was treated with METFORMIN HCL (Unit Dose: 1 G) (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Plavix Review and Plavix Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), OMEXEL (Total Daily Dose: 0.4 Mg Unit Dose: 0.4 Mg) (View Omexel Review and Omexel Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6535635-3 | Cholestasis, Hepatic Encephalopathy, Hyperammonaemia
on Nov 24, 2009 Female patient from FRANCE , 80 years of age, was diagnosed with type 2 diabetes mellitus, hemiplegia, pain (What is pain?), hypercholesterolaemia, hypertension, myocardial ischaemia and was treated with Glucor (View Usage). Patient had the following side effects: cholestasis, hepatic encephalopathy, hyperammonaemia. Glucor dosage: Unit Dose: 1 Df. During the same period patient was treated with BACLOFENE WINTHROP 10 MG (Unit Dose: 0.5 Df) (View Baclofene Winthrop 10 Mg Review and Baclofene Winthrop 10 Mg Label ), DI ANTALVIC (Unit Dose: 2 Df) (View Di-antalvic Review and Di-antalvic Label ), TAHOR 40 MG (Unit Dose: 1 Df) (View Tahor 40 Mg Review and Tahor 40 Mg Label ), GLIMEPIRIDE TEVA 2 MG (Unit Dose: 1 Df) (View Glimepiride Teva 2 Mg Review and Glimepiride Teva 2 Mg Label ), ESIDREX 25 MG (Unit Dose: 1 Df) (View Esidrex 25 Mg Review and Esidrex 25 Mg Label ), ATENOLOL TEVA (100 Mg) (View Atenolol Teva Review and Atenolol Teva Label ), AMLODIPINE EG (10 Mg) (View Amlodipine Eg Review and Amlodipine Eg Label ), KARDEGIC (Unit Dose: 1 Df) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6535608-0 | Confusional State, Locked-in Syndrome, Therapeutic Agent Toxicity
Patient was taking Glucor (View Usage). After Glucor was administered, patient had the following side effects: confusional state, locked-in syndrome, therapeutic agent toxicity on Dec 28, 2009 from FRANCE Additional patient health information: Female patient , 82 years of age, . Glucor dosage: Total Daily Dose: 200 Mg Unit Dose: 100 Mg. During the same period patient was treated with TERALITHE (Total Daily Dose: 300 Mg Unit Dose: 300 Mg) (View Teralithe Review and Teralithe Label ), CRESTOR (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6532704-9 | Confusional State, Locked-in Syndrome, Therapeutic Agent Toxicity
Adverse event was reported on Dec 28, 2009 by a Female patient taking Glucor (View Usage) (Dosage: Total Daily Dose: 200 Mg Unit Dose: 100 Mg) . Location: FRANCE , 82 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, locked-in syndrome, therapeutic agent toxicity. During the same period patient was treated with TERALITHE (Total Daily Dose: 300 Mg Unit Dose: 300 Mg) (View Teralithe Review and Teralithe Label ), CRESTOR (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6473653-4 | Cholestasis, Hepatic Encephalopathy, Hyperammonaemia
on Nov 24, 2009 Female patient from FRANCE , 80 years of age, was diagnosed with type 2 diabetes mellitus, hemiplegia, pain (What is pain?), hypercholesterolaemia, hypertension, myocardial ischaemia and was treated with Glucor (View Usage). Patient had the following side effects: cholestasis, hepatic encephalopathy, hyperammonaemia. Glucor dosage: Unit Dose: 1 Df. During the same period patient was treated with BACLOFENE WINTHROP 10 MG (Unit Dose: 0.5 Df) (View Baclofene Winthrop 10 Mg Review and Baclofene Winthrop 10 Mg Label ), DI ANTALVIC (Unit Dose: 2 Df) (View Di-antalvic Review and Di-antalvic Label ), TAHOR 40 MG (Unit Dose: 1 Df) (View Tahor 40 Mg Review and Tahor 40 Mg Label ), GLIMEPIRIDE TEVA 2 MG (Unit Dose: 1 Df) (View Glimepiride Teva 2 Mg Review and Glimepiride Teva 2 Mg Label ), ESIDREX 25 MG (Unit Dose: 1 Df) (View Esidrex 25 Mg Review and Esidrex 25 Mg Label ), ATENOLOL TEVA (100 Mg) (View Atenolol Teva Review and Atenolol Teva Label ), AMLODIPINE EG (10 Mg) (View Amlodipine Eg Review and Amlodipine Eg Label ), KARDEGIC (Unit Dose: 1 Df) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6311386-5 | Blood Creatinine Increased, Convulsion, Creatinine Renal Clearance Decreased, Dehydration, Hypoglycaemia, Renal Failure Acute
on Aug 06, 2009 Male patient from FRANCE , 38 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: blood creatinine increased, convulsion, creatinine renal clearance decreased, dehydration, hypoglycaemia, renal failure acute. Glucor dosage: Total Daily Dose: 3 Df. During the same period patient was treated with METFORMIN (Total Daily Dose: 3 Df) (View Metformin Review and Metformin Label ), AMAREL (Total Daily Dose: 1 Df) (View Amarel Review and Amarel Label ), NOZINAN (View Nozinan Review and Nozinan Label ), TERCIAN (View Tercian Review and Tercian Label ), MICROPAKINE (View Micropakine Review and Micropakine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6219652-9 | Cytolytic Hepatitis
Patient was taking Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis on May 26, 2009 from FRANCE Additional patient health information: Male patient , 70 years of age, . Glucor dosage: . During the same period patient was treated with RIFINAH (300mg/150mg) (View Rifinah Review and Rifinah Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), TAHOR (View Tahor Review and Tahor Label ), RIMACTANE (Total Daily Dose: 600 Mg Unit Dose: 600 Mg) (View Rimactane Review and Rimactane Label ), OFLOCET (As Used: 200 - 200 Mg Unit Dose: 200 Mg) (View Oflocet Review and Oflocet Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6215712-7 | Cytolytic Hepatitis
Adverse event was reported on May 26, 2009 by a Male patient taking Glucor (View Usage) (Dosage: ) . Location: FRANCE , 70 years of age, Patient had the following side effects: cytolytic hepatitis. During the same period patient was treated with RIFINAH (300mg/150mg) (View Rifinah Review and Rifinah Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), TAHOR (View Tahor Review and Tahor Label ), RIMACTANE (Total Daily Dose: 600 Mg Unit Dose: 600 Mg) (View Rimactane Review and Rimactane Label ), OFLOCET (As Used: 200 - 200 Mg Unit Dose: 200 Mg) (View Oflocet Review and Oflocet Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5838270-5 | Cholestasis, Eosinophilia, Erythema, Leukocytosis, Ocular Icterus, Oedema Peripheral, Pyrexia
on Jul 22, 2008 Female patient from FRANCE , 44 years of age, was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: cholestasis, eosinophilia, erythema, leukocytosis, ocular icterus, oedema peripheral, pyrexia. Glucor dosage: . Patient was hospitalized.

5754934-6 | Cardio-respiratory Arrest, Diarrhoea, Infarction
on Aug 23, 2006 Male patient from FRANCE , 68 years of age, weighting 198.4 lb, was diagnosed with unevaluable event and was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, diarrhoea, infarction. Glucor dosage: . During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), ELISOR (View Elisor Review and Elisor Label ), VFEND (Unit Dose: 400 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Unit Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (Total Daily Dose: 360 Mg Unit Dose: 120 Mg) (View Isoptin Review and Isoptin Label ), ALDACTONE (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), LASILIX (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lasilix Review and Lasilix Label ).

5746111-X | Hypoglycaemic Coma
Patient was taking Glucor (View Usage). Patient had the following side effects: hypoglycaemic coma on May 07, 2008 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with type 2 diabetes mellitus and. Glucor dosage: Total Daily Dose: 100 Mg. During the same period patient was treated with AMAREL (Total Daily Dose: 4 Mg) (View Amarel Review and Amarel Label ), METFORMIN HCL (Total Daily Dose: 850 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), TANAKAN (View Tanakan Review and Tanakan Label ), PIASCLEDINE (View Piascledine Review and Piascledine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

5745039-9 | Hypoglycaemic Coma
Adverse event was reported on May 07, 2008 by a Male patient taking Glucor (View Usage) (Dosage: Total Daily Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, hypoglycaemia and. Location: FRANCE , 70 years of age, After Glucor was administered, patient had the following side effects: hypoglycaemic coma. During the same period patient was treated with AMAREL (Total Daily Dose: 4 Mg) (View Amarel Review and Amarel Label ), METFORMIN HCL (Total Daily Dose: 850 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), TANAKAN (View Tanakan Review and Tanakan Label ), PIASCLEDINE (View Piascledine Review and Piascledine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), G30% (View G30% Review and G30% Label ), G10% (View G10% Review and G10% Label ). Patient was hospitalized.

5634620-3 | Abdominal Pain, Lactic Acidosis, Mechanical Ventilation, Respiratory Distress, Vomiting
on Dec 17, 2007 Female patient from FRANCE , 56 years of age, was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), lactic acidosis, mechanical ventilation, respiratory distress, vomiting. Glucor dosage: . During the same period patient was treated with STAGID (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), ATHYMIL (View Athymil Review and Athymil Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5579923-6 | Abdominal Pain, Lactic Acidosis, Mechanical Ventilation, Respiratory Distress, Vomiting
on Dec 17, 2007 Female patient from FRANCE , 56 years of age, was treated with Glucor (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), lactic acidosis, mechanical ventilation, respiratory distress, vomiting. Glucor dosage: . During the same period patient was treated with STAGID (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), ATHYMIL (View Athymil Review and Athymil Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5576909-2 | Subdural Haematoma
Patient was taking Glucor (View Usage). After Glucor was administered, patient had the following side effects: subdural haematoma on Dec 11, 2007 from FRANCE Additional patient health information: Female patient , 75 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Glucor dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ZOCOR (View Zocor Review and Zocor Label ), NISIS (View Nisis Review and Nisis Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), NOOTROPYL (View Nootropyl Review and Nootropyl Label ). Patient was hospitalized.

5573469-7 | Subdural Haematoma
Adverse event was reported on Dec 11, 2007 by a Female patient taking Glucor (View Usage) (Dosage: Total Daily Dose: 150 Mg) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , 75 years of age, Patient experienced the following unwanted or unexpected effects: subdural haematoma. During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ZOCOR (View Zocor Review and Zocor Label ), NISIS (View Nisis Review and Nisis Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), NOOTROPYL (View Nootropyl Review and Nootropyl Label ). Patient was hospitalized.

5150265-6 | Dysphagia, Flatulence, Throat Tightness
on May 29, 2006 Female patient from FRANCE , 46 years of age, weighting 211.6 lb, was diagnosed with diabetes mellitus, unevaluable event, pain in extremity and was treated with Glucor (View Usage). Patient had the following side effects: dysphagia, flatulence, throat tightness. Glucor dosage: . During the same period patient was treated with ART 50 (View Art 50 Review and Art 50 Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CERAZETTE (View Cerazette Review and Cerazette Label ).

5124676-9 | Cardio-respiratory Arrest, Diarrhoea, Infarction
on Aug 23, 2006 Male patient from FRANCE , 68 years of age, weighting 198.4 lb, was diagnosed with unevaluable event and was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: cardio-respiratory arrest, diarrhoea, infarction. Glucor dosage: . During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VFEND (Unit Dose: 400 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Unit Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (Total Daily Dose: 360 Mg Unit Dose: 120 Mg) (View Isoptin Review and Isoptin Label ), ALDACTONE (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), LASIX (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lasix Review and Lasix Label ).

5123946-8 | Cardio-respiratory Arrest, Diarrhoea, Infarction
Patient was taking Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, diarrhoea, infarction on Aug 23, 2006 from FRANCE Additional patient health information: Male patient , 68 years of age, weighting 198.4 lb, was diagnosed with unevaluable event and. Glucor dosage: . During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VFEND (Unit Dose: 400 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Unit Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (Total Daily Dose: 360 Mg Unit Dose: 120 Mg) (View Isoptin Review and Isoptin Label ), ALDACTONE (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), LASIX (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lasix Review and Lasix Label ).

5116366-3 | Dehydration, Fall, Hypoglycaemia, Malaise
Adverse event was reported on Jul 10, 2006 by a Male patient taking Glucor (View Usage) (Dosage: ) was diagnosed with unevaluable event and. Location: FRANCE , 70 years of age, weighting 211.6 lb, Patient had the following side effects: dehydration, fall (What is fall?), hypoglycaemia, malaise. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), STAGID (View Stagid Review and Stagid Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), KERLONE (View Kerlone Review and Kerlone Label ), FORTZAAR (View Fortzaar Review and Fortzaar Label ). Patient was hospitalized.

5100872-1 | Depressed Level Of Consciousness, Hyponatraemia
on Sep 05, 2006 Male patient from FRANCE , 83 years of age, was diagnosed with diabetes mellitus, ischaemic cardiomyopathy and was treated with Glucor (View Usage). After Glucor was administered, patient had the following side effects: depressed level of consciousness, hyponatraemia. Glucor dosage: . During the same period patient was treated with ALDACTONE (Total Daily Dose: 75 Mg Unit Dose: 75 Mg) (View Aldactone Review and Aldactone Label ), DAONIL (View Daonil Review and Daonil Label ), SECTRAL (Total Daily Dose: 200 Mg Unit Dose: 200 Mg) (View Sectral Review and Sectral Label ). Patient was hospitalized.

5091120-X | Cardio-respiratory Arrest, Diarrhoea, Infarction
on Aug 23, 2006 Male patient from FRANCE , 68 years of age, weighting 198.4 lb, was diagnosed with unevaluable event and was treated with Glucor (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, diarrhoea, infarction. Glucor dosage: . During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VFEND (Unit Dose: 400 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Unit Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (Total Daily Dose: 360 Mg Unit Dose: 120 Mg) (View Isoptin Review and Isoptin Label ), ALDACTONE (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Aldactone Review and Aldactone Label ), LASILIX (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lasilix Review and Lasilix Label ).

5080438-2 | Angina Unstable, Coronary Artery Disease, Myocardial Infarction
Patient was taking Glucor (View Usage). Patient had the following side effects: angina unstable, coronary artery disease (What is coronary artery disease?), myocardial infarction on Jul 20, 2000 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with ill-defined disorder, cardiac failure congestive and. Glucor dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DISCOTRINE (View Discotrine Review and Discotrine Label ), ZOCOR (View Zocor Review and Zocor Label ), LASILIX (View Lasilix Review and Lasilix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5078803-2 | Cardio-respiratory Arrest, Diarrhoea, Myocardial Infarction
Adverse event was reported on Aug 11, 2006 by a Male patient taking Glucor (View Usage) (Dosage: ) was diagnosed with unevaluable event and. Location: FRANCE , 68 years of age, weighting 198.4 lb, After Glucor was administered, patient had the following side effects: cardio-respiratory arrest, diarrhoea, myocardial infarction. During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VFEND (Total Daily Dose: 200 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Total Daily Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASILIX (View Lasilix Review and Lasilix Label ).